We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Macrophage Nanoparticles Created as Sepsis Treatment

By LabMedica International staff writers
Posted on 16 Jan 2018
Print article
Image: An artist illustration of nanoparticles coated with macrophage cell membranes (Photo courtesy of Nanomaterials & Nanomedicine Laboratory, University of California, San Diego).
Image: An artist illustration of nanoparticles coated with macrophage cell membranes (Photo courtesy of Nanomaterials & Nanomedicine Laboratory, University of California, San Diego).
A novel approach for treating sepsis is based on nanoparticles (so-called nanosponges) coated with cell membranes isolated from immune macrophages.

Sepsis is a life-threatening condition that arises when the body's response to infection causes injury to its own tissues and organs. Sepsis is caused by an immune response triggered by an infection. Most commonly, the infection is bacterial, but it may also be from fungi, viruses, or parasites. Common locations for the primary infection include lungs, brain, urinary tract, skin, and abdominal organs.

Currently, there are no effective clinically available sepsis treatments, and care remains primarily supportive. In an effort to develop an effective sepsis treatment, investigators at the University of California, San Diego (USA) fabricated a novel type of macrophage biomimetic nanoparticle or nanosponge. The nanoparticles, made by wrapping polymeric cores with cell membrane derived from macrophages, possessed an antigenic exterior the same as the source cells.

The investigators reported in the October 24, 2017, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences that by acting as macrophage decoys, these nanoparticles bound and neutralized endotoxins that would otherwise have triggered immune activation. In addition, these macrophage-like nanoparticles sequestered proinflammatory cytokines and inhibited their ability to potentiate the sepsis cascade.

In a mouse Escherichia coli bacteremia model, treatment with macrophage mimicking nanoparticles, termed M-Phi-NPs, reduced proinflammatory cytokine levels, inhibited bacterial dissemination, and ultimately conferred a significant survival advantage to infected mice.

"A wide range of endotoxins and pro-inflammatory cytokines naturally bind to macrophage cell membranes, so these nanosponges serve as universal traps for a broad spectrum of sepsis-causing molecules," said senior author Dr. Liangfang Zhang, professor of nanoengineering at the University of California, San Diego. "They can work across different bacterial genus, species and strains, and since they are covered in actual macrophage cell membranes, they can pass as the body's own immune cells and circulate the bloodstream without being evicted."

Related Links:
University of California, San Diego

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.